1. India Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Kaya Limited

Kaya Limited

KAYA.BO
Kaya LimitedIN flagBombay Stock Exchange
249.85
INR
+6.05
- -
3.82BMarket Cap
Kaya Limited
KAYA.BO
(Bombay Stock Exchange)

Recent

price

249.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
257.63
286.81
315.35
307.32
322.04
300.56
210.36
247.95
288.23
156.17
165.97
- -
151.71
Revenue per Share
24.64
6.82
-22.33
-16.22
-12.23
-41.66
-29.1
-52.69
-89.15
-98.91
63.95
- -
-65.58
Basic EPS, GAAP
-5.16
-28.95
-26.1
-35.49
-9.14
29.15
21.99
10.67
28.95
2.19
-21.83
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
10.45
-12.14
-29.04
-71.1
-127.75
-156.34
-209.76
-299.8
-398.9
-334.74
- -
10.36
Book Value per Share
134.06
140.76
93.04
76.89
42.46
-10.98
-38.69
-76.04
-136.27
-175.41
-107.89
- -
-105.3
Tangible Book Value per Share
13
13
13
13
13
13
13
13
13
13
13
- -
15
Basic Weighted Avg Shares
3,323
3,699
4,089
4,004
4,204
3,927
2,748
3,239
3,765
2,040
2,172
2,225
2,225
Sales/Revenue/Turnover
7.63
-0.96
-8.61
-5.45
-2
-4.78
-11.73
-10.55
-12.14
-1.87
-9.1
-25.18
-25.18
Operating Margin (%)
116
169
200
243
291
753
601
625
601
630
436
440
440
Depreciation Expense
318
88
-289
-211
-160
-544
-380
-688
-1,165
-1,292
837
-962
-962
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
9.57
2.38
-7.08
-5.28
-3.8
-13.86
-13.83
-21.25
-30.93
-63.34
38.53
-43.23
-43.23
Profit Margin (%)
1,065
859
-39
-173
-656
-941
-1,039
-902
-1,061
-1,843
-763
-1,001
-1,001
Working Capital
- -
- -
188
135
190
1,252
1,174
1,567
2,098
2,267
2,327
2,555
2,555
LT Debt
2,346
2,564
2,301
2,118
1,589
823
549
-10
-1,031
-2,268
-1,395
-1,528
-1,528
Total Equity
- -
-1.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
116.63
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
130.52
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-255.94
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
253
- -
401
LT Borrowings
1,609
- -
1,492
LT Finance Leases
913
- -
1,063
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
- -
15
Market Capitalization
6,298
5,592
3,494

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,113
- -
722
Cash, Cash Equivalents & STI
708
- -
431
Accounts Receivable, Net
7
- -
6
Inventories
226
- -
201
Total Current Liabilities
1,454
- -
1,724
Payables & Accruals
- -
- -
- -
ST Debt
253
- -
401
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
982.8%
1,990.54%
9.55%
Free Cash Flow
-159.37%
-220.58%
-29.7%
Net Income, GAAP
-48.82%
-43.69%
-214.94%
Sales/Revenue/Turnover
-2.6%
-0.56%
2.44%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
597
507
544
944
2,040
2025
518
525
581
547
2,172
2026
528
538
600
558
2,225

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-7.88
-8.91
-6.86
- -
-98.91
2025
78.61
-11.97
2.81
-5.36
63.95
2026
-10.76
-12.35
-23.41
-18.28
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Sea Mild Biotechnology Co., Ltd. (7516.TWO)
Warpaint London PLC (WPNTF)
Creightons Plc (CRL.L)
Kobayashi Pharmaceutical Co., Ltd. (4967.T)
PT Unilever Indonesia Tbk (UNLRF)
Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.NS)
Business
Kaya Limited is a skincare, haircare, and bodycare treatment provider operating a network of over 75 clinics across more than 26 cities in India and maintains a presence in multiple Middle Eastern countries. The company offers dermatological services and solutions including fairness and pigmentation treatments, laser hair removal, anti-aging skin care, and personal care products such as face washes, cleansers, toners, moisturizers, sunscreens, serums, and oral supplements. Kaya's product portfolio features science-based, efficacious formulations under its brand Kaya, including recent launches like the Kaya Ultra Glow Sunserum with Lumicyn™ for hyperpigmentation, Kaya Skin Elixir – 24K Gold, Hair Bond Repair Therapy Leave-in Mask, and a range of Nutra+ supplements targeting skin and hair health. Founded in 2003 and headquartered in India, Kaya operates primarily in the consumer services sector focusing on dermatological and aesthetic health. Recent strategic changes include Kaya's exit from the Middle East market through the divestiture of its subsidiaries Kaya DMCC and Kaya FZE to Humania GCC Holding Limited, alongside transferring trademark rights for the region. This divestment reflects a strategic focus on strengthening and growing its Indian market operations where it has reported continuous revenue growth. In parallel, Kaya has entered into an exclusive collaboration with Marico for the sales and marketing of its science-based personal care product range outside its clinics, leveraging Marico’s distribution capabilities to expand brand presence and accessibility across channels. These operational moves and product innovations demonstrate Kaya’s emphasis on consolidating its core dermatological services while expanding its scientifically advanced skincare product portfolio through partnerships and focused market presence.